Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
104.8
109.1
108.42
111.5
107.07
Last
1988081
3130677
4410777
3761400
3956669
Volume
+0.77% +4.10% -0.62% +2.84% -3.97% Change
Sales 2020
2 022 M 301 M 301 M
Net income 2020
567 M 84,5 M 84,5 M
Net Debt 2020
849 M 127 M 127 M
P/E ratio 2020
79,5x
Yield 2020
0,17%
Sales 2021
2 739 M 408 M 408 M
Net income 2021
477 M 71,0 M 71,0 M
Net Debt 2021
1 059 M 158 M 158 M
P/E ratio 2021
99,3x
Yield 2021
0,19%
Capitalization
44 905 M 6 688 M 6 688 M
EV / Sales 2020
22,6x
EV / Sales 2021
16,8x
Nbr of Employees
1 328
Free-Float
100%
Betta Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the research and development, manufacturing, sales and marketing of drugs to treat malignant tumors, diabetes, cardiovascular and cerebrovascular diseases. The Company’s core product is icotinib, which is a kind of antineoplastic agent. Its products also include burn pain relieving plaster, oryzanol vitamin B1 and vitamin B6 tablets....
Notations Surperformance© of Betta Pharmaceuticals Co., Ltd.
Trading Rating : Investor Rating :
All news about BETTA PHARMACEUTICALS CO., LTD.
- No features available -
News in other languages on BETTA PHARMACEUTICALS CO., LTD.
- No features available -
Chart BETTA PHARMACEUTICALS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BETTA PHARMACEUTICALS CO., LTD.
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
7
Average target price
80,22 CNY
Last Close Price
111,50 CNY
Spread / Highest target
-22,0%
Spread / Average Target
-28,1%
Spread / Lowest Target
-34,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
